Skip to content
mirodenafil

Structure via PubChem · Public domain (PubChem)

EntityQ6873840· pop 6· linked from 286 articles

mirodenafil

Sign in to save

Mirodenafil is a PDE5 inhibitor used to treat erectile dysfunction. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the brand name Mvix, offered both as tablets (50 mg and 100 mg) and as orally dissolving films (50 mg).

Chemical data

Formula
C26H37N5O5S
Molecular weight
531.7 g/mol
IUPAC name
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one
SMILES
CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC
InChIKey
MIJFNYMSCFYZNY-UHFFFAOYSA-N
XLogP
2.2
Polar surface area
125 Ų
H-bond donors
2
H-bond acceptors
8
Formal charge
0

via PubChem

Wikidata facts

Mass
531.252
Show 2 more facts
chemical formula
C₂₆H₃₇N₅O₅S
Commons category
Mirodenafil
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Mirodenafil is a PDE5 inhibitor used to treat erectile dysfunction. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the brand name Mvix, offered both as tablets (50 mg and 100 mg) and as orally dissolving films (50 mg).

Despite several clinical trials having been conducted, mirodenafil has not been approved for use in the United States by the US Food and Drug Administration.

Excerpted from Wikipedia’s “mirodenafil” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0